BioSpace News Archive

The Government of Canada welcomes the report on border testing and quarantine measures from the COVID-19 Testing and Screening Expert Advisory Panel, issued on May 27, 2021, and thanks the members for their important work

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as of May 26, 2021.

Nautilus Biotechnology, Inc. (“Nautilus Biotechnology” or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, today announced the company will be participating in the upcoming Goldman Sachs 42nd Annual Global Healthcare Conference. Nautilus’ management is scheduled to present on Thursday, June 10th at 3:00 p.m. Eastern Time/12:00 p.m. Pacific Time.

IRVINE, CA, and HERSTAL, BELGIUM – 27 May 2021 – MDxHealth SA a commercial-stage innovative molecular diagnostics company, held its annual general shareholders’ meeting and an extraordinary general shareholders’ meeting

AIDS Healthcare Foundation, the world’s largest provider of HIV/AIDS care globally, calls on the International Monetary Fund to immediately support the worldwide scale-up of COVID-19 vaccinations by providing $100 billion in emergency grants to struggling countries.

Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Universidade do Grande Rio Professor José de Souza Herdy (“UNIGRANRIO”

Healthcare industry leader brings deep Pharmacy Benefit Management experience to Citizens Rx with a commitment of delivering best-in-class service to clients while ensuring the best health outcomes for their members

August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined existing investor Oak HC/FT.

GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that Chief Executive Officer Rachel King will provide a company overview at the Jefferies 2021 Virtual Healthcare Conference. Ms. King’s presentation will take place from 2:30 to 2:55 p.m. on June 3, 2021.

Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Sesen Bio President and CEO Dr. Thomas Cannell will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 4, 2021.